Showing 1 - 12 results of 12 for search 'Adrian M Di Bisceglie', query time: 0.05s Refine Results
  1. 1
    CD81 binding regions of hepatitis C virus remain conserved after liver transplantation

    CD81 binding regions of hepatitis C virus remain conserved after liver transplantation by Andre C. Lyra, Xiaofeng Fan, Adrian M. Di Bisceglie

    Get full text
    Article
  2. 2
    A novel target enrichment strategy in next-generation sequencing through 7-deaza-dGTP-resistant enzymatic digestion

    A novel target enrichment strategy in next-generation sequencing through 7-deaza-dGTP-resistant enzymatic digestion by Peng Peng, Yanjuan Xu, Adrian M. Di Bisceglie, Xiaofeng Fan

    Published 2020-09-01
    Get full text
    Article
  3. 3
    Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components.

    Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components. by Hangeun Kim, Keith Meyer, Adrian M Di Bisceglie, Ranjit Ray

    Published 2014-01-01
    Get full text
    Article
  4. 4
    High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy.

    High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy. by Weihua Wang, Xiaoan Zhang, Yanjuan Xu, George M Weinstock, Adrian M Di Bisceglie, Xiaofeng Fan

    Published 2014-01-01
    Get full text
    Article
  5. 5
    Template-dependent multiple displacement amplification for profiling human circulating RNA

    Template-dependent multiple displacement amplification for profiling human circulating RNA by Weihua Wang, Yi Ren, Yang Lu, Yuan Xu, Seth D. Crosby, Adrian M Di Bisceglie, Xiaofeng Fan

    Published 2017-07-01
    Get full text
    Article
  6. 6
    A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes

    A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes by Stephen A. Harrison, Nadege Gunn, Guy W. Neff, Anita Kohli, Liping Liu, Abbey Flyer, Lawrence Goldkind, Adrian M. Di Bisceglie

    Published 2021-09-01
    Get full text
    Article
  7. 7
    Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.

    Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma. by Mary Ann Comunale, Lucy Rodemich-Betesh, Julie Hafner, Mengjun Wang, Pamela Norton, Adrian M Di Bisceglie, Timothy Block, Anand Mehta

    Published 2010-08-01
    Get full text
    Article
  8. 8
    Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients.

    Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients. by Maureen J Donlin, Nathan A Cannon, Rajeev Aurora, Jia Li, Abdus S Wahed, Adrian M Di Bisceglie, John E Tavis, Virahep-C Study Group

    Published 2010-02-01
    Get full text
    Article
  9. 9
    Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection.

    Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection. by Anne Lamontagne, Ronald E Long, Mary Ann Comunale, Julie Hafner, Lucy Rodemich-Betesh, Mengjun Wang, Jorge Marrero, Adrian M Di Bisceglie, Timothy Block, Anand Mehta

    Published 2013-01-01
    Get full text
    Article
  10. 10
    A Real‐World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET‐HCC

    A Real‐World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET‐HCC by Roniel Cabrera, Amit G. Singal, Massimo Colombo, R. Kate Kelley, Hannah Lee, Andrea R. Mospan, Tim Meyer, Pippa Newell, Neehar D. Parikh, Bruno Sangro, K. Rajender Reddy, Stephanie Watkins, Richard C. Zink, Adrian M. Di Bisceglie

    Published 2021-03-01
    Get full text
    Article
  11. 11
    Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis

    Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis by Kavita Radhakrishnan, Adrian M. Di Bisceglie, K. Rajender Reddy, Joseph K. Lim, Josh Levitsky, Mohamed A. Hassan, Jama M. Darling, Jordan J. Feld, Lucy Akushevich, Monika Vainorius, David R. Nelson, Michael W. Fried, Robert S. Brown Jr., Norah A. Terrault

    Published 2019-10-01
    Get full text
    Article
  12. 12
    A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study.

    A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic h... by Donna M Evon, Paul W Stewart, Jipcy Amador, Marina Serper, Anna S Lok, Richard K Sterling, Souvik Sarkar, Carol E Golin, Bryce B Reeve, David R Nelson, Nancy Reau, Joseph K Lim, K Rajender Reddy, Adrian M Di Bisceglie, Michael W Fried

    Published 2018-01-01
    Get full text
    Article

Search Tools: